Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer.

Lewis AM, Ough M, Hinkhouse MM, Tsao MS, Oberley LW, Cullen JJ.

Mol Carcinog. 2005 Aug;43(4):215-24. Erratum in: Mol Carcinog. 2017 Jul;56(7):1825-1834.

PMID:
16003741
2.

Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma.

Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ.

Free Radic Res. 2004 Nov;38(11):1223-33.

PMID:
15621700
3.

Treatment of pancreatic cancer cells with dicumarol induces cytotoxicity and oxidative stress.

Lewis A, Ough M, Li L, Hinkhouse MM, Ritchie JM, Spitz DR, Cullen JJ.

Clin Cancer Res. 2004 Jul 1;10(13):4550-8.

4.

Redox regulation of pancreatic cancer cell growth: role of glutathione peroxidase in the suppression of the malignant phenotype.

Liu J, Hinkhouse MM, Sun W, Weydert CJ, Ritchie JM, Oberley LW, Cullen JJ.

Hum Gene Ther. 2004 Mar;15(3):239-50.

PMID:
15018733
5.

Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.

Cullen JJ, Hinkhouse MM, Grady M, Gaut AW, Liu J, Zhang YP, Weydert CJ, Domann FE, Oberley LW.

Cancer Res. 2003 Sep 1;63(17):5513-20.

6.

Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase.

Weydert C, Roling B, Liu J, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ.

Mol Cancer Ther. 2003 Apr;2(4):361-9.

7.

The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma.

Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, Oberley LW.

Cancer Res. 2003 Mar 15;63(6):1297-303.

8.

The effect of phosphodiesterase inhibition on gallbladder motility in vitro.

Lindaman BA, Hinkhouse MM, Conklin JL, Cullen JJ.

J Surg Res. 2002 Jun 15;105(2):102-8.

PMID:
12121694
9.

Mechanisms of impaired gallbladder contractile response in chronic acalculous cholecystitis.

Merg AR, Kalinowski SE, Hinkhouse MM, Mitros FA, Ephgrave KS, Cullen JJ.

J Gastrointest Surg. 2002 May-Jun;6(3):432-7.

PMID:
12022997
10.

Characterization of the off response to electrical field stimulation in gallbladder smooth muscle.

Cullen JJ, Hinkhouse MM, Conklin JL.

J Surg Res. 2000 Jan;88(1):8-12.

PMID:
10644459
11.

Gastric emptying of liquids and postprandial pancreatobiliary secretion are temporarily impaired during endotoxemia.

Cullen JJ, Titler S, Ephgrave KS, Hinkhouse MM.

Dig Dis Sci. 1999 Nov;44(11):2172-7.

PMID:
10573359
12.

Changes in intestinal transit and absorption during endotoxemia are dose dependent.

Cullen JJ, Doty RC, Ephgrave KS, Hinkhouse MM, Broadhurst K.

J Surg Res. 1999 Jan;81(1):81-6.

PMID:
9889063
13.

Effect of endotoxin on canine colonic motility and transit.

Spates ST, Cullen JJ, Ephgrave KS, Hinkhouse MM.

J Gastrointest Surg. 1998 Jul-Aug;2(4):391-8.

PMID:
9841998
14.

Endotoxin temporarily impairs canine colonic absorption of water and sodium.

Cullen JJ, Spates ST, Ephgrave KS, Hinkhouse MM.

J Surg Res. 1998 Jan;74(1):34-8.

PMID:
9536970
15.

Endotoxin temporarily impairs canine jejunal absorption of water, electrolytes, and glucose.

Cullen JJ, Hemann LL, Ephgrave KS, Hinkhouse MM.

J Gastrointest Surg. 1997 May-Jun;1(3):286-91.

PMID:
9834360
16.

The effect of endotoxin on canine jejunal motility and transit.

Cullen JJ, Caropreso DK, Ephgrave KS, Hemann LL, Hinkhouse MM.

J Surg Res. 1997 Jan;67(1):54-7.

PMID:
9070181

Supplemental Content

Loading ...
Support Center